SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Whitehawk Therapeutics, Inc. (WHWK)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
4.5 / 10
Letters
3
Latest Activity
May. 22, 2025
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
May. 22, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Whitehawk Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes the company's responsibilit… Read Filing EDGAR
May. 13, 2025 CORRESP Neutral/Informational Low The correspondence from Whitehawk Therapeutics, Inc. addresses comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested confi… Read Filing EDGAR
May. 7, 2025 UPLOAD Concern from SEC Moderate The SEC has issued a comment letter to Whitehawk Therapeutics regarding their Form 10-K for the fiscal year ended December 31, 2025. The SEC has specifically requested confirmatio… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.